Arca
Skip to content
Tools
Tools

MicroVue Bb Plus EIA is packaged as a kit which contains all reagent components to…

Recall Z-0417-2015, part of FDA recall event 69545. See Diagnostic Hybrids's company page.

Diagnostic Hybrids Inc started this Class II device recall on Oct 16, 2014 (voluntary: firm initiated); FDA lists it as terminated, terminated Sep 3, 2015.

  • Classification: Class II
  • Started: Oct 16, 2014
  • Status: Terminated

Why It Was Recalled

Class II

Samples are quantitating incorrectly, with approximately 50% higher concentration values than previously reported and historically documented.

Record

Product
MicroVue Bb Plus EIA is packaged as a kit which contains all reagent components to perform the test. In vitro diagnostic.
Quantity
171
Lots and codes
Model Number A027; Lot Number 018186; (self-affixed, EDMA Code: 12 01 02 04 00; Complement Component Bb)
Distribution
Worldwide Distribution - USA, including AL, CO, CT, FL, KY, MN, NC, NV, OH, PA, and WA; and, the countries of Canada, China, India, and Switzerland.
Recalling firm
Diagnostic Hybrids Inc, Athens, OH, United States
How the firm notified
Letter
FDA classified
Sep 3, 2015

Diagnostic Hybrids Inc's Other Recalls

Newest first, one product per recall event; search them all

FDA's weekly Enforcement Report, as openFDA publishes it. A recall is classified by how likely the product is to cause harm: Class I is the most serious. openFDA device enforcement reports

Esc

Type a name: a tool, a company, a drug or brand, a condition, a gene or a state. Identifiers like K231234, NCT05012345 or NDA 215866 open their record.

Logos are each company's own site icon, matched by name through Wikidata, or logos provided by Logo.dev.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.